Clinical Stage Programs
Program
MOA
Indications
IND
Phase I
Phase II
Phase III
Rights
LM-302
Anti-Claudin18.2 ADC
Gastrointestinal cancer
Global available
LM-108
Anti-CCR8 mAb
Solid tumors
Global available
LM-101
Anti-SIRPα mAb
Solid tumors & hematologic malignancies
Global available
LM-305
Anti-GPRC5D ADC
Multiple Myeloma
AstraZeneca (Global)
LM-24C5
CEACAM5 BsAb
CRC, GI cancer, lung cancer
Global available
LM-299
anti-PD-1 x anti-VEGF BsAb
Solid tumors
MSD (Global)
Clinical Stage Programs
LM-302
Gastrointestinal cancer
IND
Phase I
Phase II
Phase III
MOA
Anti-Claudin18.2 ADC
Rights
Global available
LM-108
Solid tumors
IND
Phase I
Phase II
Phase III
MOA
Anti-CCR8 mAb
Rights
Global available
LM-101
Solid tumors & hematologic malignancies
IND
Phase I
Phase II
Phase III
MOA
Anti-SIRPα mAb
Rights
Global available
LM-305
Multiple Myeloma
IND
Phase I
Phase II
Phase III
MOA
Anti-GPRC5D ADC
Rights
AstraZeneca (Global)
LM-24C5
CRC, GI cancer, lung cancer
IND
Phase I
Phase II
Phase III
MOA
CEACAM5 BsAb
Rights
Global available
LM-299
Solid tumors
IND
Phase I
Phase II
Phase III
MOA
anti-PD-1 x anti-VEGF BsAb
Rights
MSD (Global)
Preclinical Stage Programs
Program
MOA
Indications
Discovery
PCC
IND-enabling
Rights
LM-001
anti-NaPi2b ADC
Solid tumors
Global available
LM-002
anti-CDH17 ADC
Solid tumors
Global available
LM-003
anti-CLDN6 ADC
Solid tumors
Global available
LM-004
anti-CEACAM5 ADC
Solid tumors
Global available
LM-005
anti-GPC3 ADC
Solid tumors
Global available
LM-006
anti-LIV1 ADC
Solid tumors
Global available
LM-007
anti-FRα ADC
Biparatopic
Biparatopic
Solid tumors
Global available
Clinical Stage Programs
LM-001
Solid tumors
Discovery
PCC
IND-enabling
MOA
anti-NaPi2b ADC
Rights
Global available
LM-002
Solid tumors
Discovery
PCC
IND-enabling
MOA
anti-CDH17 ADC
Rights
Global available
LM-003
Solid tumors
Discovery
PCC
IND-enabling
MOA
anti-CLDN6 ADC
Rights
Global available
LM-004
Solid tumors
Discovery
PCC
IND-enabling
MOA
anti-CEACAM5 ADC
Rights
Global available
LM-005
Solid tumors
Discovery
PCC
IND-enabling
MOA
anti-GPC3 ADC
Rights
Global available
LM-006
Solid tumors
Discovery
PCC
IND-enabling
MOA
anti-LIV1 ADC
Rights
Global available
LM-007
Solid tumors
Discovery
PCC
IND-enabling
MOA
anti-FRα ADC
Biparatopic
Biparatopic
Rights
Global available
